ADHD Therapeutics Market to 2018

Reportstack has announced a new market research publication on ADHD Therapeutics Market to 2018  - New Diagnostic Parameters for Adult ADHD Offer Hope for Higher Rates of Treatment which provides insights into the up-and-coming trends of the ADHD market in seven major markets: the US, the top five European countries (France, Germany, Italy, Spain and the UK) and Japan. The report includes market forecasts to 2019, detailed pipeline analysis, in-depth profiling of major products and details of recent industry deals. The report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by team of industry experts. The ADHD therapeutics market is expected to show strong growth in Spain and Japan, with Compound Annual Growth Rates (CAGRs) of 8% and 15% respectively. However, the total revenues of these markets are still expected to be much lower than the largest market, the US, which is expected to reach $6,260m by 2018. This is due to the much higher diagnosis rates for both adults and children with ADHD in the US.

Scope

Current and future treatment and diagnosis trends for ADHAD
Market forecasts for ADHD across seven major markets
Analysis of the developmental pipelines for ADHD
Information on recent industry deals

Reasons to Buy

Understand how the ADHD market has developed and is continuing to develop within the featured markets
Predict which products are likely to be most successful in the future
Gain an understanding of the possible market available for specific products

To view the table of contents and know more details please visit ADHD Therapeutics Market to 2018 report.